Hippocampal neuronal nitric oxide synthase mediates the stress-related depressive behaviors of glucocorticoids by downregulating glucocorticoid receptor

Journal of Neuroscience

Volumn 31, Issue 21, 2011, Pages 7579-7590

  Zhou, Qi Gang ^a   Zhu, Li Juan ^a   Chen, Chen ^a   Wu, Hai Yin ^a   Luo, Chun Xia ^a   Chang, Lei ^a   Zhu, Dong Ya ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYCLIC GMP; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GUANYLATE CYCLASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; PEROXYNITRITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; ENZYME INHIBITION; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; DEPRESSION; DOWN-REGULATION; GLUCOCORTICOIDS; GUANYLATE CYCLASE; HIPPOCAMPUS; MICE; MICE, 129 STRAIN; MICE, INBRED ICR; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE I; ORGAN CULTURE TECHNIQUES; PEROXYNITROUS ACID; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; STRESS, PSYCHOLOGICAL;

EID: 79957641891     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0004-11.2011     Document Type: Article

References (41)

1. Bartolomucci A, Leopardi R (2009) Stress and depression: preclinical research and clinical implications. PLoS One 4:e4265.
2. Becker N, Wierenga CJ, Fonseca R, Bonhoeffer T, Nägerl UV (2008) LTD induction causes morphological changes of presynaptic boutons and reduces their contacts with spines. Neuron 60:590-597.
3. Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamine. Nat Rev Neurosci 7:137-151.
4. Boyle MP, Brewer JA, Funatsu M, Wozniak DF, Tsien JZ, Izumi Y, Muglia LJ (2005) Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc Natl Acad Sci U S A 102:473-478.
5. Bredt DS, Snyder SH (1994) Transient nitric oxide synthase neurons in embryonic cerebral cortical plate, sensory ganglia, and olfactory epithelium. Neuron 13:301-313.
6. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH (1991) Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7:615-624.
7. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8:766-775.
8. Chiavegatto S, Dawson VL, Mamounas LA, Koliatsos VE, Dawson TM, Nelson RJ (2001) Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase. Proc Natl Acad Sci U S A 98:1277-1281.
9. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, Lipton SA (2009) S-nitrosylation of Drp1 mediates beta-amyloid-ralated mitochondrial fission and neuronal injury. Science 324:102-105.
10. Chvanov M, Gerasimenko OV, Petersen OH, Tepikin AV (2006) Calciumdependent release of NO from intracellular S-nitrosothiols. EMBO J25: 3024-3032.
11. Csibi A, Communi D, Müller N, Bottari SP (2010) Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms. PLoS One 5:e10070.
12. de Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M (1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301.
13. de Kloet ER, Joëls M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6:463-475.
14. Grippo AJ, Sullivan NR, Damjanoska KJ, Crane JW, Carrasco GA, Shi J, Chen Z, Garcia F, Muma NA, Van de Kar LD (2005) Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats. Psychopharmacology 179:769-780.
15. Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS (2005) Protein Snitrosylation: purview and parameters. Nat Rev Mol Cell Biol 6:150-166.
16. Hooper DC, Spitsin S, Kean RB, Champion JM, Dickson GM, Chaudhry I, Koprowski H (1998) Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A 95:675-680.
17. Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:894-902.
18. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS (1993) A redox-based mechanism for the neuroprotec-tive and neurodestructive effects of nitric oxide and related nitrosocompounds. Nature 364:626-632.
19. Marcondes S, Cardoso MH, Morganti RP, Thomazzi SM, Lilla S, Murad F, De Nucci G, Antunes E (2006) Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration. Proc Natl Acad Sci U S A 103:3434-3439.
20. Marshall HE, Hess DT, Stamler JS (2004) S-nitrosylation: physiological regulation of NF-κB. Proc Natl Acad Sci U S A 101:8841-8842.
21. Martinowich K, Manji H, Lu B (2007) Mew insights into BDNF function in depression and anxiety. Nat Neurosci 10:1089-1093.
22. Matsubara T, Funato H, Kobayashi A, Nobumoto M, Watanabe Y (2006) Reduced glucocorticoid receptor alpha expression in mood disorder patients and first-degree relatives. Biol Psychiatry 59:689-695.
23. Nagano T (1999) Practical methods for detection of nitric oxide. Luminescence 14:283-290.
24. Nelson RJ, Demas GE, Huang PL, Fishman MC, Dawson VL, Dawson TM, Snyder SH (1995) Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 378:383-386.
25. Nott A, Watson PM, Robinson JD, Crepaldi L, Riccio A (2008) S-nitrosylation of histone deacetylase 2 induces chromatin remodeling in neurons. Nature 455:411-415.
26. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, Dwyer S, Holmans P, Marchini JL, Spencer CC, Howie B, Leung HT, Hartmann AM, Möller HJ, Morris DW, Shi Y, et al. (2008) Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40:1053-1055.
27. Pariante CM, Miller AH (2001) Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49:391-404.
28. Rangaswami H, Marathe N, Zhuang S, Chen Y, Yeh JC, Frangos JA, Boss GR, Pilz RB (2009) Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction. J Biol Chem 284:14796-14808.
29. Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, Wienker T, Töpner T, Fritzen S, Walter U, Schmitt A, Fallgatter AJ, Lesch KP (2006) A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 11:286-300.
30. Revest JM, Di Blasi F, Kitchener P, Rougé-Pont F, Desmedt A, Turiault M, Tronche F, Piazza PV (2005) The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids. Nat Neurosci 8:664-672.
31. Ridder S, Chourbaji S, Hellweg R, Urani A, Zacher C, Schmid W, Zink M, Hörtnagl H, Flor H, Henn FA, Schütz G, Gass P (2005) Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J Neurosci 25:6243-6250.
32. Rozeboom AM, Akil H, Seasholtz AF (2007) Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice. Proc Natl Acad Sci U S A 104:4688-4693.
33. Sasaki M, Gonzalez-Zulueta M, Huang H, Herring WJ, Ahn S, Ginty DD, Dawson VL, Dawson TM (2000) Dynamic regulation of neuronal NO synthase transcription by calcium influx through a CREB family transcription factor-dependent mechanism. Proc Natl Acad Sci U S A 97:8617-8622.
34. Shinkai T, Ohmori O, Hori H, Nakamura J (2002) Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol Psychiatry 7:560-563.
35. Stamler JS, Lamas S, Fang FC (2001) Nitrosylation: the prototypic redoxbased signaling mechanism. Cell 106:675-683.
36. Stoppini L, Buchs PA, Muller D (1991) A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37:173-182.
37. Szabo ́ C, Ischiropoulos H, Radi R (2007) Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 8:662-680.
38. Zhang J, Huang XY, Ye ML, Luo CX, Wu HY, Hu Y, Zhou QG, Wu DL, Zhu LJ, Zhu DY (2010) Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A-receptor in modulating anxiety-related behaviors. J Neurosci 30:2433-2441.
39. Zhang P, Wang YZ, Kagan E, Bonner JC (2000) Peroxynitrite targets the epidermal growth factor receptor, Raf-1, and MEK independently to activate MAPK. J Biol Chem 275:22479-22486.
40. Zhou L, Zhu DY (2009) Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide 20:223-230.
41. Zhou QG, Hu Y, Hua Y, Hu M, Luo CX, Han X, Zhu XJ, Wang B, Xu JS, Zhu DY (2007) Neuronal nitric oxide synthase contributes to chronic stressinduced depression in mice. J Neurochem 103:1843-1854.